Health Care | Pharmaceuticals, Biotechnology & Life Sciences | Pharmaceuticals
NASDAQ | Common Stock
BiondVax Pharmaceuticals Ltd., a development stage biopharmaceutical company, focuses on developing, manufacturing, and commercializing products for the prevention and treatment of infectious and autoimmune diseases, and other illnesses in Israel.
The company has licensing and collaboration agreement with Max Planck Society and University Medical Center Göttingen for the development and commercialization of COVID-19 nanosized antibody (NanoAb); and development and commercialization of NanoAbs for various other disease indications.
The company was incorporated in 2003 and is headquartered in Jerusalem, Israel.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Aug 11, 23 | -1.11 Increased by +44.50% | -0.91 Decreased by -21.98% |
| Apr 17, 23 | -1.08 Increased by +60.17% | -0.10 Decreased by -975.30% |
| Nov 30, 22 | 0.01 Increased by +258.73% | -0.10 Increased by +110.00% |
| Aug 25, 22 | -0.20 Decreased by -2.05 K% | -1.05 Increased by +80.95% |
| Jun 1, 22 | -2.00 Decreased by -75.44% | -1.00 Decreased by -100.00% |
| Mar 28, 22 | -2.70 Decreased by -8.95 K% | -0.85 Decreased by -217.65% |
| Nov 30, 21 | -0.01 Increased by +98.38% | - |
| Aug 26, 21 | -0.01 Increased by +99.92% | - |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Jun 30, 23 | 0.00 Decreased by N/A% | -3.76 M Increased by +68.84% | Decreased by N/A% Decreased by N/A% |
| Mar 31, 23 | 2.02 M Increased by +N/A% | 5.60 M Increased by +159.44% | Increased by +277.64% Decreased by N/A% |
| Dec 31, 22 | 0.00 Decreased by -100.00% | 5.60 M Increased by +152.05% | Increased by +N/A% Increased by +N/A% |
| Sep 30, 22 | 0.00 Decreased by N/A% | 9.79 M Increased by +208.25% | Increased by +N/A% Decreased by N/A% |
| Jun 30, 22 | 0.00 Decreased by N/A% | -12.07 M Decreased by -0.68% | Decreased by N/A% Decreased by N/A% |
| Mar 31, 22 | 0.00 Decreased by N/A% | -9.42 M Increased by +33.21% | Decreased by N/A% Decreased by N/A% |
| Dec 31, 21 | 2.75 M Increased by +N/A% | -10.75 M Increased by +23.72% | Decreased by -391.30% Decreased by N/A% |
| Sep 30, 21 | 0.00 Decreased by N/A% | -9.05 M Decreased by -116.35% | Decreased by N/A% Decreased by N/A% |